[1] PubMed ID: | 31281502 |
Disease Name: | Liver Cirrhosis |
Sample: | liver tissues,blood |
Dysfunction Pattern: | Interaction[ ECM and TGFβ pathway] |
Validated Method: | RIP//ChIP |
Description: | It was found lncRNA ENSMUST00000158992, named as Scarna10, was remarkably up-regulated in mouse fibrotic livers according to the microarray data. We observed that the transcript of SCARNA10 was increased in the serum and liver from patients with advanced hepatic fibrosis.Mechanistically, RNA immunoprecipitation (RIP) assays demonstrated that SCARNA10 physically associated with polycomb repressive complex 2 (PRC2). Additionally, our results demonstrated that SCARNA10 functioned as a novel positive regulator of TGFβ signaling in hepatic fibrogenesis by inhibiting the binding of PRC2 to the promoters of the genes associated with ECM and TGFβ pathway, thus promoting the transcription of these genes. |
Causality: | Yes |
Causal Description: | Furthermore, we found that SCARNA10 promoted liver fibrosis both in vitro and in vivo through inducing hepatocytes (HCs) apoptosis and HSCs activation. |
Clinical-realted Application: | |
|